The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 30, 2003

Filed:

Apr. 24, 2001
Applicant:
Inventors:

Tiruvoor G. Nagaraja, Manhattah, KS (US);

George C. Stewart, Manhattan, KS (US);

Sanjeev K. Narayanan, Irving, TX (US);

Muckatira M. Chengappa, Manhattan, KS (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 3/902 ; C12N 1/511 ; C12N 1/20 ; C67H 2/102 ; C07H 2/104 ;
U.S. Cl.
CPC ...
A61K 3/902 ; C12N 1/511 ; C12N 1/20 ; C67H 2/102 ; C07H 2/104 ;
Abstract

The gene expressing leukotoxin was sequenced and cloned. The leukotoxin open reading frame (lktA) is part of a multi-gene operon containing 9,726 bp, and encoding a protein containing 3,241 amino acids with an overall molecular weight of 335,956 daltons. The protein encoded by the gene was truncated into five polypeptides having overlapping regions by truncating the full length gene into five different sections and amplifying, expressing, and recovering the protein encoded by each of these sections. Additionally, a region upstream of the gene was sequenced and the polypeptide encoded by that nucleotide sequence was purified and isolated. These polypeptides along with the full length protein are then tested to determine their immunogenicity and protective immunity in comparison to the efficacy of immunization conferred by inactivated native leukotoxin in culture supernatant.


Find Patent Forward Citations

Loading…